Global

Pharmaceutical Executive Global Digest®

July 29, 2020

Click here to download the August 2020 edition.

COVID-19: Expanding Remote Patient Services during Lockdown

July 20, 2020

Stephanie Hill looks at the efforts made by patient solutions providers in the UK to build and support services outside the hospital environment during the pandemic.

Is Drug Production Heading Back to Europe From Abroad?

July 09, 2020

Pharmaceutical Executive

Pandemic sparks call for European manufacturing renaissance.

The Specter of Compulsory Licensing Haunts Vaccine Debate

June 11, 2020

Industry prospects at mercy of public discourse, policy shifts.

A New, Less Friendly Normal Looms for European Drugmakers

May 10, 2020

Pharmaceutical Executive

Pandemic fallout could spell fundamental business and policy shifts.

Iraq: Stabilizing a Growing Market

May 06, 2020

Ali Mosawi writes about the misconceptions of Iraq's often inhospitable landscape, the essential role of international expertise in driving growth, and how the sector has adapted to meet the challenges of the COVID-19 pandemic.

There’s No Easing the Price-vs.-Value Debate

April 08, 2020

Pharmaceutical Executive

With coronavirus a stark backdrop, European initiative pushes for “fair” drug prices to spur investment in pharma innovation.

Getting through the EU MDR and IVDR Whirlwind: Steps to Compliance

March 11, 2020

Medical devices manufacturers and pharma companies alike should review their compliance strategies as the EU Medical Device Regulation Date of Application approaches.

Blood Feud Divides Europe Over Plasma Shortfalls

March 09, 2020

Pharmaceutical Executive

The collection of source plasma for new therapies igniting debate.

Chemotherapy vs Immunotherapy: China's Liver Cancer Market Outlook

March 09, 2020

Jianan Huang outlines the market prospects for first-line treatments for liver cancer treatment in China.